CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes ...

One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...

A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and ...

Vertex Pharmaceuticals (NASDAQ:VRTX) has posted new data from a Phase 1/2/3 study for zimislecel (VX-880), its experimental ...

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced simultaneous presentation and publication of updated data from the Phase 1/2 portion of the Phase 1/2/3 FORWARD-101 clinical trial of ...

Diabetes in pets, especially in dogs and cats, can show symptoms similar to those in humans. Early detection is essential to ...

A future launch of the dual monitor would only bolster the company’s wide range of diabetes management options. In addition ...

Researchers at Indiana University Indianapolis are developing a small device to test blood sugar levels by breath.

Heat and humidity can pose some challenges for people with diabetes. But with these smart strategies, it’s possible to enjoy ...